CysBio ApS: Financial statements 2019
CVR: 40270752
Source: annual report 2019, Danish Business Authority
18/02/2019 – 31/12/2019
CysBio ApS (CVR 40270752) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -2,058,324 and a net result of DKK -5,151,558. Equity in the 2019 report amounted to DKK 17,246,742. The solvency ratio was 89.7%.
- Gross Profit
- DKK -2,058,324
- Profit/Loss
- DKK -5,151,558
- Equity
- DKK 17,246,742
- Total Assets
- DKK 19,232,640
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of February 25, 2019, Henrik Meyer has joined the board of directors of CysBio ApS.
As of February 25, 2019, Alex Toftgaard Nielsen has joined the board of directors of CysBio ApS.
As of February 25, 2019, Zhimin Wang has joined the board of directors of CysBio ApS.
As of February 25, 2019, Danmarks Tekniske Universitet is registered as an owner of CysBio ApS with an ownership share of 10%.
As of February 18, 2019, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of CysBio ApS.
As of February 18, 2019, Henrik Meyer is registered as director of CysBio ApS.
CysBio ApS was founded on February 18, 2019.
About CysBio ApS
CysBio ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Alex Toftgaard Nielsen. The board consists of Alex Toftgaard Nielsen (chair), Christian Bille Jendresen and Xu Chaofeng. The company's owners include Danmarks Tekniske Universitet, Hemanshu Share Holding ApS and Christian Bille Jendresen Holding ApS. According to the 2025 annual report, the company had an average of 13 employees. In 2025, the company reported a gross profit of DKK 9,930,247 and a net result of DKK 124,708 compared with DKK -12,602,635 the year before. Equity in the 2025 report amounted to DKK -8,792,805.